With Augmentation Near Five Percent, Clinics Debate Who Gets to Say No

LAGOS — Roughly one in twenty humans now carries some neural or somatic augmentation, and this week the debate turned from whether adults may enhance themselves to who may decide for those who cannot yet consent. At a clinical-ethics forum here, practitioners pressed the case that with Somaform Augmetics' neural-interface line still under an open and contested safety review, no minor should receive elective cognitive implants until that review resolves. "Five percent sounds like a fringe until you learn it is your daughter's classmates," said Dr. Folasade Balogun, a pediatric neurologist who chairs the clinic's consent board. "We are being asked to install permanence into people who cannot yet imagine being different adults." Augmentation advocates counter that a blanket delay denies therapeutic benefit to children with genuine deficits. No policy emerged; the review remains unfinished, as it has all year. What the forum produced instead was a narrower consensus: that consent, for the young, is a decision that cannot be taken back.